The Egyptian Drug Authority operates under a strict legislative framework encompassing its establishing law and executive regulations, alongside relevant laws on clinical research, industrial establishments, biologicals, pharmaceutical products, and medical devices. This legal framework aims to control the pharmaceutical market and ensure the safety, manufacturing, and export of all medical products.This legislative aspect is presented in the consolidated table
1-The Law Establishing the Organization and its Executive Regulations
| law/Dcree | Issue date | about |
| Law No. 151 for Year 2019 | 25/08/2019 |
Promulgating law establishing the Egyptian Authority for Unified Procurement, Medical Supply and Technology Management (AUPP) and the Egyptian Drug Authority (EDA) |
| Prime Minister's Decree No. (777) of 2020 | 29/03/2020 | Promulgating the Executive Regulation of the law establishing the Egyptian Authority for Unified Procurement, Medical Supply and Technology Management (AUPP) and Egyptian Drug Authority (EDA) Promulgated by Law No. 151 for Year 2019. |
2-Relevant Laws and Executive Regulations
| law/Dcree | Issue date | about |
| 18/09/1941 | On Suppression of Fraud and Deception As Amended By Laws Nos. 106/1980 and 281/1994 |
|
| 10/03/1955 | concerning Practice of Pharmacy Profession On behalf of the nation | |
| 05/06/1960 | Regarding Anti-Narcotics and the Regulation of their Use and Traffic | |
| Law No. 15 of 2017 | 03/05/2017 | Promulgating the Law Facilitating the Procedures of Licensing the Industrial Establishments Promulgating law establishing the Egyptian Authority for Unified |
| Law No. 214 for Year 2020 | 2020 | Promulgating the law to regulate Clinical Medical Research |
| law No.8 of 2021 | 19/04/2021 | Issuing The Law of organizing blood operation and Plasma collection for manufacturing and exportation its derivative |
| President's Decree No.94 For year 1972 | 1972 | Concerning Establishing the General Egyptian Authority Products for Biological and Vaccines |
| President's Decree No.187 For year 2002 | 2002 | Concerning Converting the General Egyptian Authority for Biological Products and Vaccines to a Holding Company |
| President's Decree No.244 For year 2009 | 2009 | Regarding the issuance of the Executive Regulations of the National Organization for Research and Control of Biologicals. |
| President's Decree No.343 For year 2021 | 2021 | Concerning Issuing the Rules of Biological Products'Registration |
| President's Decree No.150For year 2022 | 14/03/2022 | regarding Reorganizing the Rules and Procedures of Re-registration of Human Pharmaceutical Products |
| Circular Letter No. (5) of 2013 | 2013 | |
| Prime Minister's Decree No. (869) of 2010 | 01/04/2010 | |
| Minister of Industry and Trade Decree No. 1082 of 2017 | 16/08/2017 | On the issuance of the Executive Regulations of the Law on Facilitating the Procedures for Licensing Industrial Establishments, issued by Law No. 15 of 2017 |
| Prime Minister's Decree No. (1818) of 2019 | 2019 | to replace the text of of article two of the aforementioned prime minister’s Decree No.(869) of 2010 |
| Prime Minister Decree No. 927 of 2022 | 12/03/2022 | On the issuance of the Executive Regulations of the Law on the Regulation of Clinical Medical Research, issued by Law No. 214 of 2020 |
| Prime Minister’s Decree No.(2603) of 2021 | 06/10/2021 | Issuing the Executive Regulation of the Law of Regulating Blood operations and plasma collection for manufacturing and exportation of its derivatives Promulgated by Law No. (8) of 2021 |